Oseltamivir Phosphate (Zydus Pharmaceuticals (USA) Inc.)
Welcome to the PulseAid listing for the Oseltamivir Phosphate drug offered from Zydus Pharmaceuticals (USA) Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Zydus Pharmaceuticals (USA) Inc. |
NON-PROPRIETARY NAME: | Oseltamivir Phosphate |
SUBSTANCE NAME: | OSELTAMIVIR PHOSPHATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | FOR SUSPENSION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-09-14 |
END MARKETING DATE: | 0000-00-00 |
Oseltamivir Phosphate HUMAN PRESCRIPTION DRUG Details:
Item Description | Oseltamivir Phosphate from Zydus Pharmaceuticals (USA) Inc. |
LABELER NAME: | Zydus Pharmaceuticals (USA) Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 6(mg/mL) |
START MARKETING DATE: | 2017-09-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70710-1165_2ee59c2e-c3c0-4ef8-b6a9-53d1a6c8c69e |
PRODUCT NDC: | 70710-1165 |
APPLICATION NUMBER: | ANDA209113 |
Other OSELTAMIVIR PHOSPHATE Pharmaceutical Manufacturers / Labelers: